Dyshidrosiform Bullous Pemphigoid With Dermatophyte Infection: An Association or Coincidence? Diagnostic Challenge of a Case and Review of the Literature.

This Case Shows the Rarity of Dyshidrosiform Bullous Pemphigoid (DBP) as it is the first case to be reported from Nepal. Also, this is the first case of a dermatophyte infection in a patient with DBP. This case underscores the need for more extensive studies on DBP to better understand its incidence, risk factors, pathophysiology, systemic associations, diagnostic workup, and treatment options.

Three Cell Wall Degrading Enzymes and Sorghum Contribute to Virulence and Resistance in the Bacterial Leaf Streak Pathosystem.

With an increasing demand for renewable fuels, bioenergy crops are being developed with high sugar content and altered cell walls to improve processing efficiency. These traits may have unintended consequences for plant disease resistance. pv.

Effectiveness of Lower Range of High-intensity Statin Therapy in Lowering LDL-C among STEMI Patients.

Background: Lipid-lowering is an important intervention to reduce cardiovascular morbidity and mortality after ST-Elevation myocardial infarction. This study aimed to assess the proportion of such patients achieving guideline-directed therapeutic low-density lipoprotein cholesterol targets while on lower-range high-intensity statin treatment.

Methods: This is a cross-sectional study conducted in Shahid Gangalal National Heart Centre, a tertiary cardiac center in Kathmandu, Nepal, from November 2021 to July 2022 among admitted acute ST-Elevation myocardial infarction patients who were prescribed a lower range of high-intensity statin therapy, Atorvastatin 40mg and Rosuvastatin 20 mg.

A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.

The prevalence of viral hepatitis among people in prisons is higher than in the general population. Screening, treatment and vaccination programmes exist within prisons to reduce the incidence of hepatitis, although lower uptake has often been reported compared to similar programmes outside of prisons. We conducted a systematic review of qualitative evidence to explore the barriers and facilitators to hepatitis B and C reduction programmes in prisons from the perspectives of people in prison, custodial staff and prison healthcare staff.